CN105145868A - Composition containing fish oil and preparation method of composition - Google Patents
Composition containing fish oil and preparation method of composition Download PDFInfo
- Publication number
- CN105145868A CN105145868A CN201410244324.XA CN201410244324A CN105145868A CN 105145868 A CN105145868 A CN 105145868A CN 201410244324 A CN201410244324 A CN 201410244324A CN 105145868 A CN105145868 A CN 105145868A
- Authority
- CN
- China
- Prior art keywords
- fish oil
- constituent
- solution
- present
- dha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000021323 fish oil Nutrition 0.000 title claims abstract description 116
- 238000002360 preparation method Methods 0.000 title claims description 17
- 239000000203 mixture Substances 0.000 title abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000470 constituent Substances 0.000 claims description 85
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 55
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 55
- 238000003756 stirring Methods 0.000 claims description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
- 239000002253 acid Substances 0.000 claims description 20
- 239000000194 fatty acid Substances 0.000 claims description 15
- -1 fatty acid ester Chemical class 0.000 claims description 14
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 13
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 13
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 13
- 229930195729 fatty acid Natural products 0.000 claims description 13
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 12
- 239000000787 lecithin Substances 0.000 claims description 12
- 235000010445 lecithin Nutrition 0.000 claims description 12
- 229940067606 lecithin Drugs 0.000 claims description 12
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 12
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 12
- 229920000053 polysorbate 80 Polymers 0.000 claims description 12
- 229940068968 polysorbate 80 Drugs 0.000 claims description 12
- 230000007935 neutral effect Effects 0.000 claims description 11
- 235000011187 glycerol Nutrition 0.000 claims description 10
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 7
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 5
- 235000013361 beverage Nutrition 0.000 abstract description 12
- 230000035622 drinking Effects 0.000 abstract description 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 108
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 54
- 229940090949 docosahexaenoic acid Drugs 0.000 description 54
- 239000012085 test solution Substances 0.000 description 37
- 239000000243 solution Substances 0.000 description 33
- 238000010438 heat treatment Methods 0.000 description 22
- 238000002474 experimental method Methods 0.000 description 20
- 238000004128 high performance liquid chromatography Methods 0.000 description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 239000007937 lozenge Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 239000002775 capsule Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 241000251468 Actinopterygii Species 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 235000019647 acidic taste Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000019688 fish Nutrition 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 239000003929 acidic solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 150000003180 prostaglandins Chemical class 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000010148 water-pollination Effects 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 239000006014 omega-3 oil Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000442132 Lactarius lactarius Species 0.000 description 1
- 241001274189 Pomatomus saltatrix Species 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 241001233037 catfish Species 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000021032 oily fish Nutrition 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
- Fats And Perfumes (AREA)
Abstract
The invention discloses a composition containing fish oil. Fish oil can be emulsified to enable the surface of fish oil to be changed from lipophilic to hydrophilic, so that fish oil can be dissolved in water. Therefore, the human body can obtain fish oil through drinking, and is supplemented with enough EPA and DHA. Furthermore, the composition has excellent thermal stability and can be added into a common beverage sold in the market, so that people can obtain fish oil from the beverage.
Description
Technical field
The present invention, about a kind of constituent with fish oil, refers to a kind of constituent especially, at least comprises an emulsifying agent, the fish oil with eicosapentaenoic acid and DHA can be dissolved in water, and have good stability.
Background technology
The fish oil (fishoil) of general indication, acquired by normally from fish (oilyfish) tissue being rich in oil, similarly be salmon, blue and white fish, catfish or sardine etc., all belong to the fish of being rich in oil; Fish oil has many effects, as reduced high cholesterol, reducing breast cancer, improve A Zihaimo disease (Alzheimer'sdisease) and Parkinson's Si disease (Parkinson'sdisease), even contributing to improving the mental disease such as anxiety and anxiety disorder; Fish oil can have above effect, and main fish oil includes eicosapentaenoic acid (eicosapentanoicacid, EPA) and DHA (docosahexaenoicacid, DHA) two kinds of aliphatic acid.
Eicosapentaenoic acid (eicosapentanoicacid, EPA) a kind of omega-fatty acid (Omega-3fattyacids) is all obtain from fish mostly, particularly salmon, and in greengrocery, nut, dark vegetable or beans also have the EPA of trace; EPA produces must one of originating of prostaglandin (prostaglandin), and prostaglandin controls the function of artery and the running of clot (bloodclotting), therefore, EPA can not obtain scarce material in health, in addition, EPA also can reduce the content of blood cholesterol and triglyceride; Because human body cannot manufacture EPA voluntarily, so EPA must obtain from food.
DHA (docosahexaenoicacid, DHA), same a kind of omega-fatty acid (Omega-3fattyacids), except can from fish obtain, marine alga be also the source of another kind of DHA; The health of adult can need appropriate DHA to maintain the running of brains, and for the child of just birth, DHA is then the element of brain development necessity, and therefore, DHA is often thought relevant with learning ability and intellectual development by people; Although the health of the mankind can manufacture the DHA of trace voluntarily, for the amount needed for health reality, still not enough to some extent, so, need by providing health more DHA via food.
EPA and DHA bis-kinds of polyunsaturated fatty acids, the important aliphatic acid of composition phosphatide, cholesteryl ester, very important to the health of the mankind, but it is busy owing to living, modern's diet changes, many people all have obvious deficiency for the picked-up of EPA and DHA, and thus health lacks the materials such as EPA and DHA; Because EPA and DHA concerns running in human brain and development, therefore, when lacking EPA and DHA, people easily produces the tendency of the mental illness such as worry or schizophrenia; In addition, more have research report to point out, human body, when lacking EPA and DHA, easily produces allergic constitution.
In order to supplementary EPA and DHA, many people directly can take the capsule containing fish oil; Because fish oil is polybasic unsaturated fatty acid, be easily oxidized, therefore, commonly using in the practice, can add vitamin E when making capsule to slow down oxidation, but vitamin E is fat-soluble, picked-up too much can be deposited in liver, cause burden of liver, form fatty liver, unhealthful; If fish oil is added in general commercial beverage, because fish oil is fat-soluble, therefore cannot be dissolved in water, and general commercial beverage is all acidity, fish oil oxidation can be increased, produce degraded, therefore, be difficult in the mode of drinking to obtain EPA and DHA at present.
In view of this, the present inventor attempts to find human body through edible beverage to obtain the method for EPA and DHA, therefore, can carry out a series of experiment, analysis and test, and after research for a long time, finally work out a kind of constituent with fish oil of the present invention and preparation method thereof.
Summary of the invention
Main purpose of the present invention, a kind of constituent with fish oil is provided, at least comprise the emulsifying agent of special allotment, the surface of fish oil is allowed to become hydrophily from lipophile by emulsified fish oil, fish oil can be dissolved in water, also can remain stable under sour environment and thermal environment, so, the materials such as EPA and DHA in fish oil can be easier to by human intake simultaneously.
Secondary objective of the present invention, provides a kind of constituent with fish oil, without the need to using capsule, can remain stable, so, can reduce the vitamin E that human intake is too much, reduce the burden of liver under sour environment and thermal environment.
In order to reach object of the present invention, the present invention proposes a kind of constituent with fish oil, fish oil heat endurance in the solution can be maintained, at least comprise:
Fish oil;
Lecithin;
The cool fatty acid ester of Beans;
Polysorbate 80; And
Glycerine;
Wherein, this fish oil contains eicosapentaenoic acid and DHA.
Have a constituent for fish oil as above, wherein, the content range of fish oil is between 10% to 20%; The content range of lecithin is between 5% to 8%; The content range of the cool fatty acid ester of Beans is between 15% to 25%; The content range of polysorbate 80 is between 20% to 30%; The content range of glycerine is between 7% to 13%.
Have a constituent for fish oil as above, the content of DHA is between 9.5mg/g ~ 19mg/g, and EPA content is between 15mg/g ~ 30mg/g.
There is a constituent for fish oil as above, be dissolvable in water in the solution of neutrality and acidity; Wherein, this neutral solution refers to the solution of pH=7, and this acid solution refers to the solution of pH=3.
There is a constituent for fish oil as above, can sugared part be contained in this solution, and the content range of this sugared part is below 10%.
There is a preparation method for the constituent of fish oil, prepared in accordance with the following steps:
(1) fish oil is added in lecithin, to form solution, and carries out stirring operation;
(2) add and add the cool fatty acid ester of Beans and polysorbate 80 to this solution, and carry out stirring operation; And
(3) interpolation glycerine and water are to this solution, and after carrying out stirring operation, to obtain the constituent with fish oil;
Wherein, this fish oil contains EPA and DHA.
There is a preparation method for the constituent of fish oil as above, in step (1), stir the uniform stirring that operation is carried out five minutes.
There is a preparation method for the constituent of fish oil as above, in step (2), stir the uniform stirring that operation is carried out ten minutes.
There is a preparation method for the constituent of fish oil as above, in step (3), stir the uniform stirring that operation is carried out ten minutes.
Have a preparation method for the constituent of fish oil as above, in step (1) in step (3), temperature is controlled between 35 DEG C to 45 DEG C
Compared with prior art, beneficial effect of the present invention is:
(1) fish oil can be dissolved in water: by constituent of the present invention, and fish oil can by emulsification effectively, and thus the oil loving surface of fish oil becomes hydrophilic surface, so, makes fish oil to be dissolved in water;
(2) thermally-stabilised and acid is stablized good: the experiment carried out through the present invention is known, constituent of the present invention, fish oil is allowed all to have good stability under sour environment and thermal environment, constituent of the present invention is added into after in general commercial beverage, the materials such as EPA and DHA are not easily along with the time produces degraded, therefore, human body is able to absorb EPA and DHA from the beverage containing constituent of the present invention;
(3) without the need to using capsule: the constituent with fish oil of the present invention, can remain stable under sour environment and thermal environment, after entering human consumption's system, fish oil structure is not easily destroyed, without the need to using capsule to take, so, the vitamin E that human intake is too much can be reduced, reduce the burden of liver.
Must in addition it is emphasised that, above-mentioned detailed description illustrates for possible embodiments of the present invention, only this embodiment and be not used to limit the scope of the claims of the present invention, all do not depart from skill spirit of the present invention do equivalence implement or change, all should be contained in this case the scope of the claims.
Accompanying drawing explanation
Fig. 1 is preparation method's flow chart of constituent of the present invention;
Fig. 2 is constituent of the present invention is in the solution of neutrality at soda acid, heats the concentration curve between four hours;
Fig. 3 is constituent of the present invention is neutral in acid-base value, and has in the solution of 10% sugared part, heats the concentration curve between four hours;
Fig. 4 be constituent of the present invention in an acidic solution, heat the concentration curve between four hours;
Fig. 5 is constituent of the present invention acid and have in the solution of 10% sugared part, heats the concentration curve between four hours;
Fig. 6 A is the schematic perspective view that a kind of constituent with fish oil of the present invention is made into lozenge;
Fig. 6 B is the side cutaway view that a kind of constituent with fish oil of the present invention is made into lozenge;
Fig. 7 is the schematic diagram that a kind of constituent with fish oil of the present invention is sealed in bag.
In figure, primary symbols illustrates:
1: lozenge;
11: fish oil layer;
12: jacket layer;
2: powder;
3: bag;
S1 ~ S3: the number of steps of preparation method of the present invention.
Detailed description of the invention
In order to a kind of water-soluble constituent containing fish oil of the present invention more clearly can be described, below will coordinate graphic, elaborate preferred embodiment of the present invention.
First a kind of composition with the constituent of fish oil of the present invention is introduced, constituent of the present invention mainly contains five kinds of compositions, comprises fish oil (fishoil), lecithin (the cool fatty acid ester of Lecithin), Beans (Myristicacidester), polysorbate 80 (Polysorbate80) and glycerine (Glycerol); Wherein, this fish oil contains EPA (eicosapentanoicacid) and DHA (docosahexaenoicacid).
In above-mentioned, the content range of fish oil is between 10% to 20%; The content range of lecithin is between 5% to 8%; The content range of the cool fatty acid ester of Beans is between 15% to 25%; The content range of polysorbate 80 is between 20% to 30%; The content range of glycerine is between 7% to 13%.
Wherein, a kind of constituent with fish oil provided by the present invention, the content of DHA is between 9.5mg/g ~ 19mg/g, and EPA content is between 15mg/g ~ 30mg/g.
A kind of fatty acid ester of the cool fatty acid ester of above-mentioned indication Beans.The present inventor does one's utmost to look for optimum emulsification agent raw material in research process, wishes to find emulsification effect strong, is convenient to again the composition applied.After a series of test, find the composition such as the lecithin cool fatty acid ester of, Beans and polysorbate 80, be applied to emulsified fish oil, have good emulsifying effectiveness, so test ratio further, finally find under specific ratio, the compositions such as the cool fatty acid ester of lecithin, Beans and polysorbate 80 have good emulsifiability, can emulsified fish oil, and the structure of fish oil can not be destroyed, make the surface of fish oil become hydrophily from lipophile.
Please refer to Fig. 1, preparation method's flow chart of constituent of the present invention, wherein, the present inventor also provides a kind of preparation method with the constituent of fish oil, at least comprise the following step: fish oil is added in lecithin by (S1), to form solution, carry out stirring operation; (S2) add and add the cool fatty acid ester of Beans and polysorbate 80 to this solution, and carry out stirring operation; And (S3) adds glycerine and water to this solution, and after carrying out stirring operation, to obtain the constituent with fish oil.
Continue above-mentioned, in step (S1), stir the uniform stirring that operation is carried out five minutes, mixing speed does not limit; In step (S2), stir the uniform stirring that operation is carried out ten minutes, mixing speed does not limit; In step (S3), stir the uniform stirring that operation is carried out ten minutes, mixing speed does not limit; In step (S1) in step (S3), temperature is controlled in about 40 DEG C, and agitating mode is general physical agitation mode; And this solution is after step (S3), the temperature range be saved can between 10 DEG C to 35 DEG C.Because fish oil is emulsified, and under general normal temperature, without being subject to special External Force Acting, fish oil all mixes with emulsifying agent on Absorbable organic halogens ground, therefore, after completing uniform stirring, constituent of the present invention be saved under general normal temperature.
So, originally cannot be dissolved in the fish oil in water completely, because the surface of fish oil is emulsified, so change hydrophily into from lipophile originally, fish oil can be dissolved in water.Specifically, experiment through the present inventor also more finds, constituent of the present invention is under sour environment and thermal environment, all can maintain stable, therefore, constituent of the present invention is not only enough dissolved in general commercial beverage, can also remain stable under sour environment and thermal environment, so, the constituent that the present invention has fish oil is more easily absorbed by the body.
The experiment that the present inventor carries out below is described, to verify a kind of stability with the constituent of fish oil of the present invention.
[experiment one]
Experiment purpose
A kind of constituent with fish oil of test the present invention, in the solution of soda acid in neutral (pH=7), observes the stability between heating four hours.
Experimental technique
(1) first test solution of soda acid in neutral (pH=7) is prepared;
(2) constituent of the present invention is dissolved in this first test solution;
(3) concentration of EPA and DHA in this first test solution is measured, and record;
(4) heating operation is carried out to this first test solution and continue four hours, often through one hour, measure the concentration of EPA and DHA in this first test solution, and record.
Wherein, this heating operation is put this first test solution into temperature and is remained in the water of 95 DEG C, to heat.
Wherein, step (3) and step (4) measure the concentration of EPA and DHA with high performance liquid chromatography (highperformanceliquidchromatography, HPLC).
Experimental result
Please refer to Fig. 2 and table one, constituent of the present invention is in the solution of neutral (pH=7), heat the concentration curve between four hours and form, wherein, before heating, the concentration of EPA and DHA measured by this first test solution is 0.6mg/ml, and set it to 100%, and during the heating operation of four hours, find that the concentration of EPA and DHA in this first test solution does not almost change, that is, constituent of the present invention makes fish oil be dissolvable in water in the first test solution, and under thermal environment, there is good stability, therefore, constituent of the present invention can maintain fish oil at soda acid in the heat endurance in neutral solution.
| Number during heating | EPA relative concentration ratio | DHA relative concentration ratio |
| 0 | 100％ | 100％ |
| 1 | 100％ | 98.5％ |
| 2 | 99％ | 99％ |
| 3 | 99％ | 100％ |
| 4 | 100％ | 100％ |
Table one
[experiment two]
Experiment purpose
General commercial beverage is all containing quantitative sugared part, and in order to determine the stability of constituent of the present invention in the solution containing sugared part, a kind of constituent with fish oil of test the present invention is neutral in acid-base value, and has the heat endurance in the solution of 10% sugared part.
Experimental technique
(1) soda acid is prepared in neutral (pH=7), and the second test solution containing 10% sugared part;
(2) constituent of the present invention is dissolved in this second test solution;
(3) concentration of EPA and DHA in this second test solution is measured, and record;
(4) heating operation is carried out to this second test solution and continue four hours, often through one hour, measure the concentration of EPA and DHA in this second test solution, and record.
Wherein, this heating operation is put this second test solution into temperature and is remained in the water of 95 DEG C, to heat.
Wherein, step (3) and step (4) measure the concentration of EPA and DHA with high performance liquid chromatography (highperformanceliquidchromatography, HPLC).
Experimental result
Please refer to Fig. 3 and table two, constituent of the present invention is being neutral (pH=7), and have in the solution of 10% sugared part, heat the concentration curve between four hours and form, wherein, before heating, the concentration of EPA and DHA measured by this second test solution is 0.6mg/ml, and set it to 100%, and between the period of heating of four hours, find that the concentration of EPA and DHA in this second test solution does not decline completely, that is, constituent of the present invention makes fish oil under thermal environment, and containing in the solution of sugared part, there is good stability, therefore, constituent of the present invention can maintain fish oil at soda acid in neutral, and containing the heat endurance in the solution of 10% sugared part.
| Number during heating | EPA relative concentration ratio | DHA relative concentration ratio |
| 0 | 100％ | 100％ |
| 1 | 100％ | 100％ |
| 2 | 101.6％ | 101.4％ |
| 3 | 100％ | 99.2％ |
| 4 | 100.5％ | 100.3％ |
Table two
[experiment three]
Experiment purpose
A kind of constituent with fish oil of test the present invention, in the solution of acid (pH=3), observes the stability between heating four hours.
Experimental technique
(1) the 3rd test solution of acid (pH=3) is prepared;
(2) constituent of the present invention is dissolved in the 3rd test solution;
(3) concentration of EPA and DHA in the 3rd test solution is measured, and record;
(4) heating operation is carried out to the 3rd test solution and continue four hours, often through one hour, measure the concentration of EPA and DHA in the 3rd test solution, and record.
Wherein, this heating operation is put the 3rd test solution into temperature and is remained in the water of 95 DEG C, to heat.
Wherein, step (3) and step (4) measure the concentration of EPA and DHA with high performance liquid chromatography (highperformanceliquidchromatography, HPLC).
Experimental result
Please refer to Fig. 4 and table three, constituent of the present invention is in acid (pH=3) solution, heat the concentration curve between four hours and form, wherein, before heating, the concentration of EPA and DHA measured by the 3rd test solution is 0.6mg/ml, and set it to 100%, and between the period of heating of four hours, find the concentration of EPA and DHA in the 3rd test solution, compared at this first test solution and this second test solution, comparatively unstable, but still maintenance high concentration, there is no obvious decline, that is, constituent of the present invention makes fish oil have good stability under sour environment and thermal environment, therefore, constituent of the present invention can maintain fish oil heat endurance in an acidic solution.
| Number during heating | EPA relative concentration ratio | DHA relative concentration ratio |
| 0 | 100％ | 100％ |
| 1 | 95.8％ | 100％ |
| 2 | 92％ | 92.9％ |
| 3 | 100％ | 107.1％ |
| 4 | 96.2％ | 93％ |
Table three
[experiment four]
Experiment purpose
The test solution of testing to make the present invention is more close to general commercial beverage, and to determine the stability of constituent of the present invention in general commercial beverage, the present inventor devises experiment four; In experiment four, prepared containing 10% sugared part, and pH value is the test solution of 3, so, a kind of constituent with fish oil of the present invention can be tested in the acid and stability that has in the solution of 10% sugared part.
Experimental technique
(1) acid (pH=3) is prepared and the 4th test solution containing 10% sugared part;
(2) constituent of the present invention is dissolved in the 4th test solution;
(3) concentration of EPA and DHA in the 4th test solution is measured, and record;
(4) heating operation is carried out to the 4th test solution and continue four hours, often through one hour, measure the concentration of EPA and DHA in the 4th test solution, and record.
Wherein, this heating operation is put the 4th test solution into a temperature and is remained in the water of 95 DEG C, to heat.
Wherein, step (3) and step (4) measure concentration with high performance liquid chromatography (highperformanceliquidchromatography, HPLC).
Experimental result
Please refer to Fig. 5 and table four, constituent of the present invention is at acid (pH=3) and have in the solution of 10% sugared part, heat the concentration curve between four hours and form, wherein, before heating, the concentration of EPA and DHA measured by the 4th test solution is 0.6mg/ml, and set it to 100%, and between the period of heating of four hours, find that the concentration of EPA and DHA in the 4th test solution is almost fair constant, that is, constituent of the present invention makes fish oil under acid environment and thermal environment, and containing in the solution of sugared part, there is good stability, therefore, constituent of the present invention can maintain fish oil really in acidity and containing the heat endurance in the solution of sugared part.
| Number during heating | EPA relative concentration ratio | DHA relative concentration ratio |
| 0 | 100％ | 100％ |
| 1 | 100.4％ | 100％ |
| 2 | 100.5％ | 100.3％ |
| 3 | 100.6％ | 100.4％ |
| 4 | 100.5％ | 100.2％ |
Table four
A kind of constituent with fish oil of the present invention, is convenient to human intake's fish oil, and below, namely the present inventor provides two kinds of modes, allows people can take constituent of the present invention.
Please refer to Fig. 6 A and Fig. 6 B, a kind of constituent with fish oil of the present invention is made into the schematic perspective view of lozenge respectively, and a kind of constituent with fish oil of the present invention is made into the side cutaway view of lozenge.From above-mentioned experiment, because composition of the present invention has good heat endurance in acidic liquid, the injury that human body hydrochloric acid in gastric juice causes can be reduced, therefore, can lozenge be made into, for human intake.As shown in Fig. 6 A and Fig. 6 B, a kind of constituent with fish oil of the present invention, lozenge 1 can be made into, wherein, this lozenge 1 is circular, and production method first constituent of the present invention is pressed into a fish oil layer 11, again with spraying mode by this fish oil layer 11 coated for a jacket layer 12, wherein, this jacket layer 12 can add different taste according to demand, allows eater have multiple mouthfeel flavour.
In addition, please refer to Fig. 7, a kind of constituent with fish oil of the present invention is sealed in the schematic diagram of bag.As shown in Figure 7, a kind of constituent with fish oil of the present invention can be made into powder 2, and this powder 2 is loaded in a bag 3, when taking, only need tear bag 3, pour in cup by powder 2, namely drinkable.Here it is to be noted that via above-mentioned experiment, know that a kind of constituent with fish oil of the present invention can maintain good stability in an acidic solution.Even in this acid solution, add sugared part, a kind of constituent with fish oil of the present invention still has good stability, and therefore, the solution in this cup, according to demand, can add syrup, or the beverage of other acidic taste, increases local flavor when drinking.In addition, bag 3 also can accommodating sodium acid carbonate and citric acid, so, when powder 2 is poured in cup, can produce the effect of foaming in cup.
Above embodiment is only exemplary embodiment of the present invention, and be not used in restriction the present invention, protection scope of the present invention is defined by the claims.Those skilled in the art can in essence of the present invention and protection domain, and make various amendment or equivalent replacement to the present invention, this amendment or equivalent replacement also should be considered as dropping in protection scope of the present invention.
Claims (10)
1. there is a constituent for fish oil, it is characterized in that, fish oil heat endurance in the solution can be maintained, at least comprise:
Fish oil;
Lecithin;
The cool fatty acid ester of Beans;
Polysorbate 80; And
Glycerine;
Wherein, this fish oil contains eicosapentaenoic acid and DHA.
2. a kind of constituent with fish oil according to claim 1, is characterized in that, wherein, the content range of fish oil is between 10% to 20%; The content range of lecithin is between 5% to 8%; The content range of the cool fatty acid ester of Beans is between 15% to 25%; The content range of polysorbate 80 is between 20% to 30%; The content range of glycerine is between 7% to 13%.
3. a kind of constituent with fish oil according to claim 1, it is characterized in that, the content of DHA is between 9.5mg/g ~ 19mg/g, and EPA content is between 15mg/g ~ 30mg/g.
4. a kind of constituent with fish oil according to claim 1, is characterized in that, is dissolvable in water in the solution of neutrality and acidity; Wherein, this neutral solution refers to the solution of pH=7, and this acid solution refers to the solution of pH=3.
5. a kind of constituent with fish oil according to claim 4, is characterized in that, can contain sugared part, and the content range of this sugared part is below 10% in this solution.
6. there is a preparation method for the constituent of fish oil, prepared in accordance with the following steps:
(1) fish oil is added in lecithin, to form solution, and carries out stirring operation;
(2) add and add the cool fatty acid ester of Beans and polysorbate 80 to this solution, and carry out stirring operation; And
(3) interpolation glycerine and water are to this solution, and after carrying out stirring operation, to obtain the constituent with fish oil;
Wherein, this fish oil contains EPA and DHA.
7. a kind of preparation method with the constituent of fish oil according to claim 6, is characterized in that, in step (1), stirs the uniform stirring that operation is carried out five minutes.
8. a kind of preparation method with the constituent of fish oil according to claim 6, is characterized in that, in step (2), stirs the uniform stirring that operation is carried out ten minutes.
9. a kind of preparation method with the constituent of fish oil according to claim 6, is characterized in that, in step (3), stirs the uniform stirring that operation is carried out ten minutes.
10. a kind of preparation method with the constituent of fish oil according to claim 6, is characterized in that, in step (1) in step (3), temperature is controlled between 35 DEG C to 45 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410244324.XA CN105145868B (en) | 2014-06-04 | 2014-06-04 | A composition containing fish oil and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410244324.XA CN105145868B (en) | 2014-06-04 | 2014-06-04 | A composition containing fish oil and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105145868A true CN105145868A (en) | 2015-12-16 |
| CN105145868B CN105145868B (en) | 2020-08-07 |
Family
ID=54787268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410244324.XA Active CN105145868B (en) | 2014-06-04 | 2014-06-04 | A composition containing fish oil and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105145868B (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1109712A (en) * | 1993-12-20 | 1995-10-11 | 三荣源Ffi株式会社(此公司为公知) | Stable emulsifying composition and food with same |
| CN101022786A (en) * | 2004-09-03 | 2007-08-22 | 南通迈特生物工程有限公司 | Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients |
| CN102552328A (en) * | 2011-12-15 | 2012-07-11 | 山东禹王制药有限公司 | Preparation method of compound fish oil nano-emulsion |
| CN103118676A (en) * | 2010-07-26 | 2013-05-22 | 富士胶片株式会社 | Fat-containing composition and oral formulation containing same |
| TW201332542A (en) * | 2012-02-10 | 2013-08-16 | Tci Co Ltd | A compound containing lutein |
| CN103416759A (en) * | 2012-05-24 | 2013-12-04 | 内蒙古蒙牛乳业（集团）股份有限公司 | DHA emulsion, preparation method thereof and applications thereof in UHT liquid milk |
-
2014
- 2014-06-04 CN CN201410244324.XA patent/CN105145868B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1109712A (en) * | 1993-12-20 | 1995-10-11 | 三荣源Ffi株式会社(此公司为公知) | Stable emulsifying composition and food with same |
| CN101022786A (en) * | 2004-09-03 | 2007-08-22 | 南通迈特生物工程有限公司 | Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients |
| CN103118676A (en) * | 2010-07-26 | 2013-05-22 | 富士胶片株式会社 | Fat-containing composition and oral formulation containing same |
| CN102552328A (en) * | 2011-12-15 | 2012-07-11 | 山东禹王制药有限公司 | Preparation method of compound fish oil nano-emulsion |
| TW201332542A (en) * | 2012-02-10 | 2013-08-16 | Tci Co Ltd | A compound containing lutein |
| CN103416759A (en) * | 2012-05-24 | 2013-12-04 | 内蒙古蒙牛乳业（集团）股份有限公司 | DHA emulsion, preparation method thereof and applications thereof in UHT liquid milk |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105145868B (en) | 2020-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103402364B (en) | Oil or fat composition and butter cream using oil or fat composition | |
| CN101505609B (en) | Fat or oil composition | |
| JP6682598B2 (en) | Fats and oil-containing foods | |
| CN107205419B (en) | Oil and fat | |
| CN104938644A (en) | Artificial zero-thans fatty acid cream | |
| CN104840389B (en) | A kind of camellia oil creams and preparation method thereof | |
| CN104168772A (en) | Food composition comprising vitamin k and saturated fat and its use | |
| JP2008154469A (en) | Oil-in-water emulsified material | |
| CN101843336A (en) | Linseed oil fat emulsion oral solution, beverage and manufacturing method thereof | |
| CN106900881A (en) | Fat or oil composition of Water-In-Oil bag oil and preparation method thereof | |
| Choudhary et al. | Palm (Elaeis guineensis jacq.) oil | |
| EP2173197B1 (en) | Process | |
| JP5471592B2 (en) | Foamable oil-in-water emulsified oil composition for room temperature | |
| CN105594889A (en) | Fat and/or oil composition for heat cooking and method for manufacturing the fat and/or oil composition for heat cooking | |
| JP7106829B2 (en) | mouse coating sensitivity enhancer | |
| Kanjilal et al. | Application of low calorie hypocholesterolemic structured lipid as potential bakery fat | |
| CN105145868A (en) | Composition containing fish oil and preparation method of composition | |
| CN103876006A (en) | Emulsifier composition, stable ready-to-use microemulsion comprising same and preparation method thereof | |
| CN105167105B (en) | A kind of constituent with Co-Q10 and preparation method thereof | |
| TWI508663B (en) | A compound containing fish oil and the processing method thereof | |
| JP5101754B2 (en) | Palm fractionated soft oil and processed emulsified food using the same | |
| JP6382588B2 (en) | Oil and fat composition for fishery processed food, plastic oil and fat composition and fishery processed food using the same | |
| JP4670008B2 (en) | Additives for rice cooking containing higher aliphatic compounds | |
| WO2012014903A1 (en) | Fat-containing composition and oral formulation containing same | |
| JP2011254707A (en) | Edible oil and foodstuff containing the edible oil |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 200131 Shanghai City Waigaoqiao Free Trade Zone No. 3 3 2 2 level 223 parts Patentee after: Baiyuete Biotechnology (Shanghai) Co.,Ltd. Patentee after: TCI Co.,Ltd. Patentee after: BAIYUETE MEFU BIOTECHNOLOGY (SHANGHAI) CO.,LTD. Patentee after: SHANGHAI BIOTECH CO.,LTD. Address before: 200131 Shanghai City Waigaoqiao Free Trade Zone No. 3 3 2 2 level 223 parts Patentee before: Baiyuete Biotechnology (Shanghai) Co.,Ltd. Patentee before: TCI Co.,Ltd. Patentee before: BAIYUETE COSMETICS (SHANGHAI) CO.,LTD. Patentee before: SHANGHAI BIOTECH CO.,LTD. |
|
| CP01 | Change in the name or title of a patent holder |